Induction of early atherosclerosis in rats using parenterally-administered lipid emulsions.
It has been demonstrated by us and other workers that rats receiving I.V. infusions of Lipofundin-S will develop aortic changes indicative of early atherosclerosis. However, different lipid emulsions which are used in the clinical setting for parenteral nutrition vary substantially in chylomicron size and fatty acid composition. Therefore, in an attempt to better understand the mechanism by which a lipid emulsion might induce vessel lesions, we compared the nature of potential aortic changes resulting from infusions of Liposyn, Intralipid, or Lipofundin-S into the tail veins of Sprague-Dawley rats. Three groups of animals received either Liposyn (N = 10), Intralipid (N = 5), or Lipofundin-S (N = 9) at the rate of 6 g fat/kg body wt/day for 10 consecutive days. A fourth group (N = 5) received saline in equivalent dose to evaluate the effect of injection volume on vessel lesion formation. The other controls (N = 6) received no injections. Rats were sacrificed 24 hrs after the last infusion, and 1 mm rings from the top of the aortic arch and proximal third of the thoracic aorta were prepared for transmission electron microscopy (TEM). Examination by TEM allows two main conclusions to be drawn for both segments of the aorta. First, all three emulsions are capable of inducing early vessel changes which include endothelial damage, platelet adherence to damaged endothelium or subendothelial collagen, intimal phagocytic cells, and intimal smooth muscle cells surrounded by collagen bundles and elastin plates. Saline-infused rats only show occasional subendothelial swelling. None of the above-described changes are seen in any of the uninjected controls. Second, Lipofundin-S induces smooth muscle penetration of the intima in 7 of 9 rats, while Liposyn causes such changes in 2 of 10 animals. This difference in the efficiency with which the two emulsions induce the most advanced changes is statistically significantly by Chi Square (p less than 0.05). Intralipid produces smooth muscle penetration of the intima in 2 of 5 rats. The composition of the three emulsions suggests that the lower percent of linoleic acid and larger chylomicron size in Lipofundin-S may account for these differences, at least in part.
Saladino
C F
CF
Department of Medicine, Nassau County Medical Center, East Meadow, New York 11554.
Klein
R A
RA
Jonas
E A
EA
D000818:Animals; D001011:Aorta / Q000648:ultrastructure; D001161:Arteriosclerosis / Q000139:chemically induced* / Q000473:pathology; D002914:Chylomicrons; D004338:Drug Combinations; D004655:Emulsions; D004730:Endothelium, Vascular / Q000648:ultrastructure; D005217:Fat Emulsions, Intravenous; D005227:Fatty Acids; D005990:Glycerol; D054709:Lecithins; D009131:Muscle, Smooth, Vascular / Q000648:ultrastructure; D010743:Phospholipids; D051381:Rats; D011919:Rats, Inbred Strains; D012450:Safflower Oil; D013024:Soybean Oil; D013997:Time Factors
D002914:Chylomicrons; D004338:Drug Combinations; D004655:Emulsions; D005217:Fat Emulsions, Intravenous; D005227:Fatty Acids; D054709:Lecithins; D010743:Phospholipids; C031435:safflower oil, soybean oil, lecithin emulsion; C046535:Lipofundin S; D013024:Soybean Oil; D012450:Safflower Oil; D005990:Glycerol